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Background: The vast majority of the 1.1 million Alu elements are retrotranspositionally inactive, where only a few
loci referred to as ‘source elements’ can generate new Alu insertions. The first step in identifying the active Alu
sources is to determine the loci transcribed by RNA polymerase III (pol III). Previous genome-wide analyses from
normal and transformed cell lines identified multiple Alu loci occupied by pol III factors, making them candidate
source elements.
Findings: Analysis of the data from these genome-wide studies determined that the majority of pol III-bound Alus
belonged to the older subfamilies Alu S and Alu J, which varied between cell lines from 62.5% to 98.7% of the
identified loci. The pol III-bound Alus were further scored for estimated retrotransposition potential (ERP) based on
the absence or presence of selected sequence features associated with Alu retrotransposition capability. Our
analyses indicate that most of the pol III-bound Alu loci candidates identified lack the sequence characteristics
important for retrotransposition.
Conclusions: These data suggest that Alu expression likely varies by cell type, growth conditions and
transformation state. This variation could extend to where the same cell lines in different laboratories present
different Alu expression patterns. The vast majority of Alu loci potentially transcribed by RNA pol III lack important
sequence features for retrotransposition and the majority of potentially active Alu loci in the genome (scored high
ERP) belong to young Alu subfamilies. Our observations suggest that in an in vivo scenario, the contribution of Alu
activity on somatic genetic damage may significantly vary between individuals and tissues.
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Alu elements are major contributors to genomic instabil-
ity [1] and genetic disease [2] due to their ability to gen-
erate new copies that randomly insert throughout the
genome and to induce non-homologous recombination
between different copies. When comparing copy num-
bers, Alu has been vastly more successful than other
non-autonomous elements, such as the retropseudogenes
and even the autonomous L1 element [3]. Alu-induced
mutagenesis is responsible for the majority of the docu-
mented instances of human retroelement insertion-
induced disease [2] and presents a retrotransposition rate* Correspondence: aengel@tulane.edu
†Equal contributors
1Tulane Cancer Center SL-66, Dept. of Epidemiology, Tulane University, 1430
Tulane Ave, New Orleans, LA 70112, USA
Full list of author information is available at the end of the article
© 2012 Oler et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orestimated up to ten-fold higher than L1 [4,5]. The human
genome contains over one million Alu inserts [3], which
can be divided into subfamilies based on specific diag-
nostic nucleotides and their evolutionary period of activ-
ity [6,7]. About 80% of Alu elements belong to the older
previously active Alu J and Alu S subfamilies [6]. Germ-
line derived evidence supports the current activity of only
the subsets of the younger Alu Y subfamilies (such asY,
Ya, and Yb)[8], although recent data appear to indicate
that Alu retrotransposition in germline and somatic tis-
sues may show different distributions [9].
Only a few Alu elements, referred to as ‘source’ or
‘master’ elements, undergo retrotransposition. Identifica-
tion of source Alu elements has been elusive, as bona
fide Alu retrotransposition events never present 5′ or 3′
transductions that could help determine a parent locus.
Because transcription by RNA polymerase III (pol III) is. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Data Source of Alu loci.
Study Method Cell lines
Canella et al. [13] ChIP-seqa for detection of
sites bound by POLR3D
IMR90
(RPC4), TFIIIB subunits
BDP1 and BRF1
Oler et al. [12] ChIP-seqa and ChIP-arrayb
for detection of sites bound
by Pol III (RPC32 subunit),
TFIIIC63 subunit, BRF1, BRF2
HeLa, Jurkat,
HEK, 293 T
Moqtaderi et al. [14] ChIP-seqa for detection of
sites bound by TFIIIC-110
HeLa, K562
subunit, TFIIIB subunits BDP1
and BRF1, Pol III (RPC155
subunit) and BRF2
aChromatin immunoprecipitation followed by massively parallel sequencing;
bchromatin immunoprecipitation followed by complementary DNA microarray
hybridization. ChIP, chromatin immunoprecipitation.
Oler et al. Mobile DNA 2012, 3:11 Page 2 of 6
http://www.mobilednajournal.com/content/3/1/11necessary for Alu retrotransposition, a first step to iden-
tify a source element is to determine the transcribing
Alu loci. There are little available data on RNA pol III
transcribed Alu loci. Current techniques using RT-PCR
approaches are unable to distinguish bona fide pol III
Alu transcripts from those pol II transcripts containing
Alu sequences (see Figure 1 for details). One of the few
sources of reliable information was generated using
primer extension and C-tail RACE, which showed a
limited amount of SINE expression ex vivo in some
cell lines [10,11]. Recently, genome-wide chromatin
immunoprecipitation (ChIP) analyses followed by par-
allel sequencing (ChIP-seq) performed by three differ-
ent laboratories identified multiple Alu loci bound by
RNA polymerase III factors [12–14]. These datasets
(Table 1) were generated from a variety of cell lines
including a relatively ‘normal’ cell line: IMR90 (a Tert-
immortalized, untransformed human lung fibroblast)
and the tumor-derived cell lines: HeLa (cervical adeno-
carcinoma), Jurkat (T-cell leukemia) and K562 (myelo-
genous leukemia). Although the binding by pol III
factors is not synonymous with transcription, these
Alu loci represent potential candidate source elements.
To evaluate these candidate elements, we retrieved the
Alu-related sequences for those enriched with pol III ini-
tiation factors (pol III or TFIIIB) in the published data-
sets [12–14] including the ‘A-tail’ and ‘unique’ region at
the 3′ flanking sequence (see schematic of an Alu in
Figure 2). Each pol III bound Alu locus was assigned a
name based on the dataset and/or cell line where it
was identified. The 3′ flanking sequence includedAAAAANAAANA
Alu within a pol II transcript
AAAAANAAANA UU
Bona fide  pol III Alu transcr
TTTT (oligo dT
TTTT (oligo dAlu  primer
Alu  primer
A
B
NNNNNNNN
NNNNNNN
PCR product
PCR product
Figure 1 RT-PCR assays are unable to distinguish between RNA pol II
containing Alu sequences. A. Schematic of a bona fide pol III Alu transcri
flanked at the 3′ end by a poly-A stretch and the unique region (blue) whi
poly-A stretch may be either homogeneous or heterogeneous containing
sequence. The Alu (orange) present within the mRNA (blue) will also have
such as 3′ RACE, rely on generating a cDNA through the reverse transcripti
types of transcripts (pol II versus pol III) contain Alu sequences flanked by a
amplification of selected cDNAs can then be performed by using a gene sp
primer to the 3′ sequence of the oligo dT (represented as ‘Ns’). The PCR pr
transcripts will yield the same type of product, thus making it difficult to deither 300 bp or up to the first pol III terminator
(which was defined as four or more thymidine resi-
dues) of the downstream genomic flanking sequence
(complete data set shown in Additional file 1: Tables
S4-S9). We then selected only those that fit the stand-
ard dimeric Alu structure, eliminating any FLAMs,
FRAMs and partial Alu elements. In addition, we
eliminated any Alu sequences that contained an in-
ternal pol III terminator as these would generate trun-
cated Alu transcripts.
A total of 162 Alu elements fit our criteria (Additional
file 1: Table S1). Several loci (24 out of 162, 14.8%) were
identified in at least two separate cell lines (Additional file
1: Table S2), suggesting potential regions preferentiallyAAAAAAAAAAAAAAAAAAAAAAAUAAA
 of variable length (several kb)
UU
ipt (between 300-600bp)
TTTT (oligo dT) 
) 
T) 
Both transcripts will yield 
the same RT-PCR product
NNNN
NNNNNNNNNNNNNNNNN
I transcribed Alu transcripts and RNA pol II transcribed mRNAs
pt. Transcripts of 300 to 600 bp in length contain an Alu body (orange)
ch is determined by the location of the pol III terminator (Us). The
non-adenosine bases. B. Schematic of an mRNA containing an Alu
an oligo dA stretch at its 3′ end. Most standard RT-PCR approaches,
on of the RNA using an oligo dT primer (black arrow). Because both
polyA stretch, both will be amplified during reverse transcription. PCR
ecific primer (in this case Alu, shown as an orange arrow) and a
oducts (shown as black bars) of the cDNAs generated by both types of
istinguish the data generated from the bona fide pol III Alu transcripts.
Canella et al, 
2010;
Oler et al,
2010;
Moqtaderi et al, 
2010
pol III
databases
(HeLa, Jurkat, 
K562, IMR90)
IMR-90
C37 7SL
B
HeLa
A
Selection of 
Alu loci
C37 M11 M19 7SL
Figure 2 Classification strategy of potentially active Alu loci. A schematic of an Alu element is on the top right, where the body is shown in
gray. X represent sequences changes differing from the consensus or non-A residues in the A-tail. Ns represent the unique flanking sequence
located downstream of the A-tail and the first RNA polymerase III terminator defined as four or more thymidine residues (TTTT). A. Flow chart
used for the identification of potentially retrotransposition competent Alu elements. Datasets from previously published data sets were
interrogated for Alu loci identified as bound by RNA polymerase III factors. A total of 162 Alu-candidate loci were retrieved and classified based
on four parameters: 1- % divergence from the consensus sequence, which was subdivided into three categories based on the % sequence
divergence from their Alu subfamily consensus (less than 5% in blue, 5 to 10% in orange and over 10% in green also classified as
retrotranspositionally inactive). 2- A-tail length, where Alu elements with A-tail lengths of equal to or over 20 bp were included as potentially
active (+). Alu elements not meeting the criteria were binned separately and not further evaluated (shown as gray symbols; -). 3- Length of the
unique sequence, scoring positive Alu elements with 20 bp or less. 4- % disruption of the A-tail sequence was scored selecting for those with
10% or less disruption. The two Alu candidates evaluated for expression (show in B) are indicated by the asterisks in the flow diagram.
ERP= estimated retrotranspositional potential. B. Expression of candidate Alu loci with retrotransposition potential. Total RNA extracts from HeLa
or IMR90 cells were hybridized with radioactively endlabeled oligomers complementary to the unique region of the Alu loci (Additional file 1:
Table S11) following a previously published protocol [24]. Results from Alu Yb8 Canella 37 (C37), Alu Sx Moq 11 h (M11), and Alu Sx Moq 19 k
(M19) are shown. An oligo complementary to a region of the 7SL RNA that does not share sequence similarity to Alu RNA: 5′-
CCGATCGGCATAGCGCACTA-3′ was used as a positive control (white arrowhead). Bracket approximates the expected location of the Alu
transcript.
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represented only once in our data set and analyses.
Although the majority of Alu elements in the genome
belong to the older Alu subfamilies (S+ J) currently,
only the ‘young’ Alu subfamilies appear to be retro-
transpositionally active. Classification of the dataset of
pol III-bound Alus revealed that the majority belong
to the older subfamilies (Table 2) consistent with pre-
viously published expression data [11]. Although the
Alu subfamily distribution from each individual cell
line showed variation, the old Alu S+ J subfamilies
represented at least two thirds and up to 98% of theidentified loci (Additional file 1: Table S3). When all
Alus are considered together, a moderately significant
association is found between pol III-binding and Alu
J + S elements in at least one cell line but not Alu Y
elements (odds ratio = 1.6, P=0.098 in Fisher’s exact
test), suggesting that pol III is approximately 1.6 times
less likely to bind to an Alu Y element than to an
Alu J or S element. Normalization of the collective
dataset for Alu subfamily copy number differences
(older Alus are vastly more abundant than younger
elements), we observe that proportionally, there are
more young Alu elements bound by pol III factors
Table 2 Alu subfamily distribution of Alu elements bound by RNA polymerase III factors.
Alu % Total # of disease % Alu % Alu loci Pol III # Pol III
subfamilya full Alus
(530,850)
cases due to a de
novo insertion
transcriptsd bound by pol III bound Alu
enrichment
bound Alu
with ERP
(%)c factorse ≥0.10
S+ J 84.5 0 (0) 66 88.4 1.0 2
Y 15.5 13 (23) 33 9.8 0.6 0
Ya5 0.63 24 (44) 0.8 1.2 2.0 0
Yb8 0.42 18 (33) 0.5 0.6 1.5 1
aIncludes all subfamily variants: for example, AluYa5, AluYa5a2, AluYa8 are classified as Ya5; bnumber of Alu elements meeting full length criteria (Details in
supplemental data); csubfamily distribution of the 55 de novo Alu elements reported to cause a disease [2,15]; danalysis was performed on transcripts isolated
from the Ntera2 (teratocarcinoma) cell line [11]; eanalyses were performed on the cumulative data obtained from studies on IMR-90 (normal untransformed Tert-
immortalized lung fibroblast) [13], HeLa (cervical adenocarcinoma), Jurkat (T-cell leukemia), HEK 293 T (T antigen-transformed kidney) [12] and K562 (myelogenous
leukemia) cells [14] (raw data and detailed analysis for each cell line included in Additional file 1: Table S3); frepresents the increase in Alu loci bound by RNA
polymerase III factors relative to copy number (that is, %AluY bound/%AluY copies in the genome, detailed analysis in Additional file 1: Table S3); gnumber of Alu
loci bound by RNA polymerase III factors with estimated retrotransposition potential (ERP) scores of ≥0.10. An ‘ideal’ Alu will have ERP score of 1.00.
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(P=0.21 and P=0.44 for AluYa5 and AluYb8, respect-
ively, in Fisher’s exact test).
In addition to the ability to be transcribed, specific se-
quence features of Alu elements can influence retrotran-
sposition efficiency [22]. Therefore, we proceeded to
evaluate the individual pol III-bound Alu loci using our
own designed dichotomous key based on the previously
identified criteria known to affect retrotransposition
rates: 1) sequence divergence from the consensus (loss
of retrotransposition efficiency with higher divergence
[22,16]); 2) A-tail length (a minimum length is required
[17]); 3) length of the unique sequence (loss of efficiency
with longer sequences [22]); and 4) A-tail homogeneity
(loss of efficiency with higher % disruptions [22]). Our
results are schematically represented in Figure 2A
(details in Additional file 1: Table S1). We selected limits
for our criteria parameters that have been shown to sig-
nificantly reduce retrotransposition levels. We also sep-
arately assigned a numerical value of the impact on
retrotransposition (‘R’) for each Alu feature variant rela-
tive to an Alu reference (Additional file 1: Tables S12-
15) to roughly calculate the ERP of each individual
Alu (Additional file 1: Table S1, column T). However,
the ERP should not be taken as the sole defining cri-
teria for in vivo predictions, as it is based on a limited
amount of data generated from engineered Alus in a
tissue culture system and does not include transcription
status. This scoring system was applied to the pol III-
bound subset as well as all Alus genome-wide using an
algorithm that incorporates each of the scoring criteria
(implemented in Perl, score_alus.pl; available upon re-
quest). As expected, young Alu elements had a higher
score genome-wide than Alu J + S elements (median
values of 0.0042 and 0.000001 for Y and J + S, respect-
ively; P= 2.2e-16 in Wilcoxon test). While pol III-bound
Alus had a higher ERP score in general than Alus notbound by pol III (median 0.000229 and 0.000001, re-
spectively; P= 0.013 in Wilcoxon test), the ERP score
for the vast majority of the pol III-bound Alus was con-
siderably lower than the arbitrarily selected minimal
threshold for retrotransposition competency of 0.20. Of
the 162 pol III-bound Alu sequences only one AluYb8
(Canella 37 from IMR90 cells) was highly conserved
relative to the consensus sequence, met the rest of the
criteria and scored 0.20 ERP (an ‘ideal’ Alu will have a
score of 1.00). In addition, it scored low in the pol III
ChIP assay [13] and Canella 37 AluYb8 transcripts were
undetectable in HeLa and IMR90 cells by northern blot
probing with end-labeled oligonucleotides complemen-
tary to the unique sequence (Figure 2B). We opted not
to use an RT-PCR approach, as it is unable to diffe-
rentiate between RNA pol II and pol III transcripts
(Figure 1). In contrast, when using a low ERP threshold
to evaluate the reference genome, several thousands of
Alus genome-wide were identified (6,103 and 1,818
Alus at ERP threshold of 0.10 or 0.20, respectively;
Additional file 1: Table S16). Furthermore, a more con-
servative threshold (ERP scores of ≥0.50) yields only
163 of genome-wide Alus (all young elements), corrob-
orating the previously proposed Alu source model that
only a small portion of Alus in the genome are likely
active [18].
The next ‘best’ candidates identified only partially met
the criteria, corresponding to three Alu loci belonging to
older S subfamilies: Moq 13 h (HeLa), Moq 11 h (HeLa)
and Moq 28 k (K562) with 5.3%, 7.8% and 9.3% se-
quence divergence from consensus, respectively. Some
of the sequence changes were within the RNA pol III A
box and in the sequences predicted to bind the SRP9
and SRP14 proteins. Lower binding of SRP9/14 would
likely reduce the retrotransposition capability of these
elements, but further testing is required. Moq 28 k
shows a very low ERP of 0.04. Interestingly, Moq 11 h
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marginal ERP values of 0.10 and 0.14, respectively. Moq
13 h showed an A-tail with high % A-tail disruption
(24.3%), which is not observed in de novo inserts [19].
The published work on Moq 11 h showed significant pol
III binding by ChIP-seq [14]. If expressed, Moq 11 h
could prove retrotranspositionally competent. However,
the RNA-seq data showed only three sequence reads in
HeLa and none in the K562 and a non-detectable tran-
script by northern blot analysis (Figure 2B). Evaluation
of expression from five other randomly selected Alu loci,
Moq 19 k (Figure 2B) and Canella 2 and 28, Oler 38 h,
and 3c, (data not shown) by northern blot analysis also
proved unsuccessful in the detection of pol III Alu tran-
scripts. Due to the sensitivity limitation of our assay, we
are unable to unambiguously confirm that these identi-
fied Alu candidate loci with the best retrotransposition
potential (Canella 37 and Moq 11 h) are transcriptionally
silent. Thus, we cannot eliminate the possibility that very
low amounts of expression may occur, resulting in retro-
transposition. Alternatively, these or other identified Alu
loci may be more efficiently expressed in other cell
types, tissues or under other conditions such as heat
shock known to increase Alu expression [20].
Presently, we are unable to rule out that any of the
other identified pol III-bound Alu candidates that par-
tially fulfill our criteria or contain borderline attributes
may undergo retrotransposition at very low rates. How-
ever, the limits of the criteria are based on the results
using a tissue culture system [21] that significantly
favors Alu activity through the overexpression of both a
tagged Alu transcript and the enzymatic machinery
required for retrotransposition(L1 ORF2 protein). This
opens the possibility that an Alu locus identified as po-
tentially active by the selected parameters may not be
able to retrotranspose under natural cellular conditions.
Thus, it is unlikely that the ‘less perfect’ Alu candidate
elements (those with low ERP scores) contribute to ret-
rotransposition in any significant manner.
Our findings indicate that up to now, most cells ana-
lyzed may support RNA pol III expression of a collection
of Alu elements, although the vast majority lack se-
quence features associated with retrotransposition com-
petence (Table 2). A striking observation is the overall
low number of detected Alu loci (162), and even lower
when considering retrotransposition potential (only
three loci from all cell lines combined had ERPs above
0.10). So why is there little to no evidence of expression
by pol III of the active younger Alu elements? Although
speculative, these data could be indicative of a general
mechanism, such as DNA methylation, that selectively
limits Alu transcription of the retrotranspositionally
competent elements. Also, it could be a reflection that
younger, less mutated retroelements still maintain mostof their CpGs making them good substrates for regula-
tion by methylation [22]. In addition, the inability to de-
tect transcripts from the candidates identified may
reflect variability in Alu expression, where the same cell
lines in different laboratories have different expression
patterns. It is possible that Alu expression varies by cell
type, growth conditions, epigenetic signals and trans-
formation state. Our observations support the hypoth-
esis that in an in vivo scenario, the contribution of Alu
activity on somatic genetic damage may significantly
vary between individuals and tissues.Additional files
Additional file 1: Table S1. Final Alu data set. Table S2. Duplicate Alu
loci (Alu locus was identified in more than one cell type). Table S3. Alu
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17, 620–628 (2010). Table S8. Retrieved Alus from IMR90, Table S7 from
Canella,D., et al. Genome Res. 20, 710–721 (2010). Table S9. Retrieved
Alus from HeLa cells, Moqtaderi, Z, et al. Nat Struct Mol Biol, 20, 635–640
(2010). Table S10. Retrieved Alus from K562 cells, Moqtaderi, Z, et al. Nat
Struct Mol Biol, 20, 635–640 (2010). Table S11. Probes for northern blot
analysis. Table S12. Numerical value assigned base on the impact of Alu
sequence divergence on retrotransposition potential. Table S13.
Numerical value assigned base on the impact of A-tail length on
retrotransposition potential. Table S14. Numerical value assigned base
on the impact of length of unique sequence on retrotransposition
potential. Table S15. Numerical value assigned base on the impact of A-
tail disruptions on retrotransposition potential. Table S16. Output of
genome-wide analysis of B box-containing Alus with ERP
(Competence_score)>= 0.10.Competing interests
The authors declare that they have no competing financial interests.Acknowledgements
This publication was made possible by Grants Number GM45668 (PD) and
P20GM103518/P20RR020152, plus R01GM079709A (to AMR-E) from the
National Institutes of Health (NIH) and the Howard Hughes Medical Institute
(AJO). An allocation of resources from the Center for High Performance
Computing at the University of Utah is gratefully acknowledged. Huntsman
Cancer Institute Biostatistics Core Facility supported by grant P30 CA042014
also participated in this work. The contents are solely the responsibility of
the authors and do not necessarily represent the official views of NCRR or
NIH. We would like to thank Prescott Deininger for his helpful comments on
the manuscript.
Author details
1Tulane Cancer Center SL-66, Dept. of Epidemiology, Tulane University, 1430
Tulane Ave, New Orleans, LA 70112, USA. 2Department of Oncological
Sciences, Huntsman Cancer Institute, and Howard Hughes Medical Institute,
University of Utah School of Medicine, Salt Lake City, UT, USA. 3Center for
Integrative Genomics (CIG), Faculty of Biology and Medicine, University of
Lausanne, Lausanne 1015, Switzerland. 4Bioinformatics and Computational
Biosciences Branch, Office of Cyber Infrastructure and Computational Biology,
National Institute of Allergy and Infectious Diseases, National Institutes of
Health, Bethesda, MD 20892, USA.
Oler et al. Mobile DNA 2012, 3:11 Page 6 of 6
http://www.mobilednajournal.com/content/3/1/11Authors’ contributions
AMR-E designed the experimental approach, directed, and performed
analyses. ST-D mined some of the Alu sequences and performed the
northern blot analyses, with the assistance of RSD. AJO mined the Alu
sequences from the Moqtaderi data files, performed the reanalysis of ChIP-
seq data, and wrote the algorithm for classification of Alus and ERP score.
AJO and BRC provided RNA-seq data. AJO, BRC and DC provided scientific
consultation on data interpretation and writing. All authors read and
approved the final manuscript
Received: 8 February 2012 Accepted: 20 June 2012
Published: 20 June 2012References
1. Xing J, Witherspoon DJ, Ray DA, Batzer MA, Jorde LB: Mobile DNA
elements in primate and human evolution. Am J Phys Anthropol 2007,
45(Suppl):2–19.
2. Belancio VP, Hedges DJ, Deininger P: Mammalian non-LTR
retrotransposons: for better or worse, in sickness and in health. Genome
Res 2008, 18:343–358.
3. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K,
Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A,
Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J,
Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R,
Sheridan A, Sougnez C, et al: Initial sequencing and analysis of the human
genome. Nature 2001, 409:860–921.
4. Xing J, Zhang Y, Han K, Salem AH, Sen SK, Huff CD, Zhou Q, Kirkness EF,
Levy S, Batzer MA, Jorde LB: Mobile elements create structural variation:
analysis of a complete human genome. Genome Res 2009, 19:1516–1526.
5. Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF, Van Meir
EG, Vertino PM, Devine SE: Natural mutagenesis of human genomes by
endogenous retrotransposons. Cell 2010, 141:1253–1261.
6. Shen MR, Batzer MA, Deininger PL: Evolution of the master Alu gene(s).
J Mol Evol 1991, 33:311–320.
7. Batzer MA, Schmid CW, Deininger PL: Evolutionary analyses of repetitive
DNA sequences. Methods Enzymol 1993, 224:213–232.
8. Stewart C, Kural D, Stromberg MP, Walker JA, Konkel MK, Stutz AM, Urban
AE, Grubert F, Lam HY, Lee WP, Busby M, Indap AR, Garrison E, Huff C, Xing
J, Snyder MP, Jorde LB, Batzer MA, Korbel JO, Marth GT: 1000 Genomes
Project: A comprehensive map of mobile element insertion
polymorphisms in humans. PLoS Genet 2011, 7:e1002236.
9. Baillie JK, Barnett MW, Upton KR, Gerhardt DJ, Richmond TA, De Sapio F,
Brennan PM, Rizzu P, Smith S, Fell M, Talbot RT, Gustincich S, Freeman TC,
Mattick JS, Hume DA, Heutink P, Carninci P, Jeddeloh JA, Faulkner GJ:
Somatic retrotransposition alters the genetic landscape of the human
brain. Nature 2011, 479:534–537.
10. Paulson KE, Schmid CW: Transcriptional inactivity of Alu repeats in HeLa
cells. Nucleic Acids Res 1986, 14:6145–6158.
11. Shaikh TH, Roy AM, Kim J, Batzer MA, Deininger PL: cDNAs derived from
primary and small cytoplasmic Alu (scAlu) transcripts. J Mol Biol 1997,
271:222–234.
12. Oler AJ, Alla RK, Roberts DN, Wong A, Hollenhorst PC, Chandler KJ, Cassiday
PA, Nelson CA, Hagedorn CH, Graves BJ, Cairns BR: Human RNA
polymerase III transcriptomes and relationships to Pol II promoter
chromatin and enhancer-binding factors. Nat Struct Mol Biol 2010,
17:620–628.
13. Canella D, Praz V, Reina JH, Cousin P, Hernandez N: Defining the RNA
polymerase III transcriptome: genome-wide localization of the RNA
polymerase III transcription machinery in human cells. Genome Res 2010,
20:710–721.
14. Moqtaderi Z, Wang J, Raha D, White RJ, Snyder M, Weng Z, Struhl K:
Genomic binding profiles of functionally distinct RNA polymerase III
transcription complexes in human cells. Nat Struct Mol Biol 2010,
17:635–640.
15. Comeaux MS, Roy-Engel AM, Hedges DJ, Deininger PL: Diverse cis factors
controlling Alu retrotransposition: what causes Alu elements to die?.
Genome Res 2009, 19:545–555.
16. Bennett EA, Keller H, Mills RE, Schmidt S, Moran JV, Weichenrieder O, Devine
SE: Active Alu retrotransposons in the human genome. Genome Res 2008,
18:1875–1883.17. Dewannieux M, Heidmann T: Role of poly(A) tail length in Alu
retrotransposition. Genomics 2005, 86:378–381.
18. Deininger PL, Batzer MA, Hutchison CA, Edgell MH: Master genes in
mammalian repetitive DNA amplification. Trends Genet 1992, 8:307–311.
19. Roy-Engel AM, Salem AH, Oyeniran OO, Deininger L, Hedges DJ, Kilroy GE:
Active alu element "A-Tails": size does matter. Genome Res 2002,
12:1333–1344.
20. Kim C, Rubin CM, Schmid CW: Genome-wide chromatin remodeling
modulates the Alu heat shock response. Gene 2001, 276:127–133.
21. Dewannieux M, Esnault C, Heidmann T: LINE-mediated retrotransposition
of marked Alu sequences. Nat Genet 2003, 35:41–48.
22. Szpakowski S, Sun X, Lage JM, Dyer A, Rubinstein J, Kowalski D, Sasaki C,
Costa J, Lizardi PM: Loss of epigenetic silencing in tumors preferentially
affects primate-specific retroelements. Gene 2009, 448:151–167.
23. Wimmer K, Callens T, Wernstedt A, Messiaen L: The NF1 gene contains
hotspots for L1 endonuclease-dependent de novo insertion. PLoS Genet
2011, 7:e1002371.
24. Roy AM, West NC, Rao A, Adhikari P, Alemán C, Barnes AP, Deininger PL:
Upstream flanking sequences and transcription of SINEs. J Mol Biol 2000,
302:17–25.
doi:10.1186/1759-8753-3-11
Cite this article as: Oler et al.: Alu expression in human cell lines and
their retrotranspositional potential. Mobile DNA 2012 3:11.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
